imipramine has been researched along with B16 Melanoma in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gavrilova-Ruch, O | 1 |
| Schönherr, K | 1 |
| Gessner, G | 1 |
| Schönherr, R | 1 |
| Klapperstück, T | 1 |
| Wohlrab, W | 1 |
| Heinemann, SH | 1 |
1 other study available for imipramine and B16 Melanoma
| Article | Year |
|---|---|
Effects of imipramine on ion channels and proliferation of IGR1 melanoma cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Apoptosis; Cell Division; Charybdotoxin; Chloride | 2002 |